Collaborative ENTIS Study: Fetotoxic effects of ARBs exceeds that of ACE-Is

A collaboration of researchers from six ENTIS affiliated organisations and led by researchers at the Berlin TIS (Embryotox) have published their findings investigating the risk of fetotoxicity following maternal ARB or ACE-I use in pregnancy. The results of this research has suggested that, following use for at least 20 weeks of gestation, exposure to ARBs is associated with a higher risk of fetopathy (29.2%) than exposure to ACE-Is (3.20%). More information can be found here.

Photo by Thought Catalog on Unsplash